Singapore's ParkwayHealth is the first healthcare group in Southeast Asia to offer the In-Space percutaneous interspinous distraction device, a revolutionary spinal procedure.

Getting cancer treatment in Singapore is more affordable. TomoTherapy costs only $18,000 compared to $50,000 in US.

Singapore’s National University Hospital became the first in Asia to offer the first robotic assisted surgery to gynaecologic cancer patient in August 2008.

Singapore has embarked on a cell-based clinical trial that may have far-reaching implications for future cancer research and treatments.

Heart muscle-like cells developed from adult stem cells in Singapore’s National Heart Centre have been shown to interact with and improve the function of a failing heart in animal studies.

Home-grown Sirius Medical Innovation (“SMI”), a specialist in thermal-imaging solutions, announced a first collaboration with Singapore’s KK Women’s and Children’s Hospital (“KK Hospital”) to conduct clinical trials of its Thermal Imaging Medical System.

SingaporeMedicine, the government-industry partnership to develop and promote Singapore as the leading medical hub and international healthcare destination, announces its presence on Facebook.